Dr Lalchandani Labs Limited (BOM:541299)

Dr Lalchandani Labs Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	41.41	32.97	22.92	31.02	35.33
Short-Term Investments	-	-	-	1.1	-
Cash & Short-Term Investments	41.41	32.97	22.92	32.12	35.33
Cash Growth	25.58%	43.84%	-28.64%	-9.07%	22.14%
Accounts Receivable	61.05	52.59	47.04	49.66	42.15
Other Receivables	-	1.5	1.62	1.41	0.01
Receivables	67.59	55.35	50.07	53.38	48.12
Inventory	14.2	12.94	14.35	15.22	15.56
Prepaid Expenses	-	0.05	0.04	0.05	0.15
Other Current Assets	4.91	7.39	7.43	9.41	8.86
Total Current Assets	128.11	108.71	94.81	110.19	108.01
Property, Plant & Equipment	30.67	32.6	36.97	50.25	53.14
Long-Term Investments	2.67	2.65	4.07	2.41	2.41
Other Intangible Assets	2.01	2.48	2.94	3.67	4.38
Long-Term Deferred Charges	-	-	-	-	1.14
Other Long-Term Assets	0	2.51	2.58	3.01	4.42
Total Assets	176.01	157.49	149.92	177.19	181.24

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	5.11	9.57	12.27	13.38	14.32
Accrued Expenses	-	4.11	2.72	3.08	3.05
Short-Term Debt	20.64	40.67	31.4	13.66	14.23
Current Portion of Long-Term Debt	-	-	0.76	17.21	11.02
Current Income Taxes Payable	0.94	0.15	-	-	2.88
Other Current Liabilities	7.08	2.14	3.15	5.86	3.11
Total Current Liabilities	33.77	56.63	50.3	53.2	48.61
Long-Term Debt	-	-	2.63	33.17	26.18
Long-Term Deferred Tax Liabilities	0.91	1.29	1.59	1.59	1.59
Other Long-Term Liabilities	-	-	-0	-0	-0
Total Liabilities	34.67	57.92	54.52	87.96	76.38

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	86.37	43.33	43.33	43.33	43.33
Additional Paid-In Capital	-	29.22	29.22	29.22	29.22
Retained Earnings	-	26.87	22.69	16.52	32.15
Comprehensive Income & Other	54.96	0.15	0.15	0.15	0.15
Shareholders' Equity	141.33	99.57	95.4	89.22	104.85
Total Liabilities & Equity	176.01	157.49	149.92	177.19	181.24

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	20.64	40.67	34.78	64.05	51.44
Net Cash (Debt)	20.77	-7.7	-11.86	-31.92	-16.11
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	2.29	-1.77	-2.75	-7.37	-3.71
Filing Date Shares Outstanding	13.81	4.33	4.33	4.33	4.33
Total Common Shares Outstanding	13.81	4.33	4.33	4.33	4.33
Working Capital	94.34	52.08	44.51	56.98	59.4
Book Value Per Share	10.23	22.98	22.02	20.59	24.20
Tangible Book Value	139.32	97.1	92.46	85.56	100.48
Tangible Book Value Per Share	10.09	22.41	21.34	19.75	23.19
Land	-	14.62	14.62	23.03	-
Buildings	-	-	-	-	21.56
Machinery	-	52.68	51.87	51.22	49.67

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 1, 2026

Data Sources Report a data error